|
1
|
Arvizo RR, Bhattacharyya S, Kudgus RA,
Giri K, Bhattacharya R and Mukherjee P: Intrinsic therapeutic
applications of noble metal nanoparticles: Past, present and
future. Chem Soc Rev. 41:2943–2970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dreaden EC, Alkilany AM, Huang X, Murphy
CJ and El-Sayed MA: The golden age: Gold nanoparticles for
biomedicine. Chem Soc Rev. 41:2740–2779. 2012. View Article : Google Scholar
|
|
3
|
Dykman LA and Khlebtsov NG: Gold
nanoparticles in biology and medicine: Recent advances and
prospects. Acta Naturae. 3:34–55. 2011.PubMed/NCBI
|
|
4
|
Huang X, Jain PK, El-Sayed IH and El-Sayed
MA: Gold nanoparticles: Interesting optical properties and recent
applications in cancer diagnostics and therapy. Nanomedicine
(Lond). 2:681–693. 2007. View Article : Google Scholar
|
|
5
|
Giljohann DA, Seferos DS, Daniel WL,
Massich MD, Patel PC and Mirkin CA: Gold nanoparticles for biology
and medicine. Angew Chem Int Ed Engl. 49:3280–3294. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dreaden EC, Mackey MA, Huang X, Kang B and
El-Sayed MA: Beating cancer in multiple ways using nanogold. Chem
Soc Rev. 40:3391–3404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arvizo RR, Saha S, Wang E, Robertson JD,
Bhattacharya R and Mukherjee P: Inhibition of tumor growth and
metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci
USA. 110:6700–6705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arvizo RR, Rana S, Miranda OR,
Bhattacharya R, Rotello VM and Mukherjee P: Mechanism of
anti-angiogenic property of gold nanoparticles: Role of
nanoparticle size and surface charge. Nanomedicine. 7:580–587.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alkilany AM and Murphy CJ: Toxicity and
cellular uptake of gold nanoparticles: What we have learned so far?
J Nanopart Res. 12:2313–2333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Connor EE, Mwamuka J, Gole A, Murphy CJ
and Wyatt MD: Gold nanoparticles are taken up by human cells but do
not cause acute cytotoxicity. Small. 1:325–327. 2005. View Article : Google Scholar
|
|
11
|
Eccles SA, Box C and Court W: Cell
migration/invasion assays and their application in cancer drug
discovery. Biotechnol Annu Rev. 11:391–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ju D, Sun D, Xiu L, Meng X, Zhang C and
Wei P: Interleukin-8 is associated with adhesion, migration and
invasion in human gastric cancer SCG-7901 cells. Med Oncol.
29:91–99. 2012. View Article : Google Scholar
|
|
13
|
Busch J, Stephan C, Klutzny A, Hinz S,
Kempkensteffen C, Kilic E, Lein M, Weikert S, Miller K and Magheli
A: Impact of positive surgical margins on oncological outcome
following laparoscopic radical prostatectomy (LRP): long-term
results. World J Urol. 31:395–401. 2013. View Article : Google Scholar
|
|
14
|
Dassen AE, Dikken JL, van de Velde CJ,
Wouters MW, Bosscha K and Lemmens VE: Changes in treatment patterns
and their influence on long-term survival in patients with stages
I-III gastric cancer in The Netherlands. Int J Cancer.
133:1859–1866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Tan BB, Zhao Q, Fan LQ, Wang D and
Liu Y: ZNF139 promotes tumor metastasis by increasing migration and
invasion in human gastric cancer cells. Neoplasma. 61:291–298.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Manu KA, Shanmugam MK, Ramachandran L, Li
F, Fong CW, Kumar AP, Tan P and Sethi G: First evidence that
γ-tocotrienol inhibits the growth of human gastric cancer and
chemosensitizes it to capecitabine in a xenograft mouse model
through the modulation of NF-κB pathway. Clin Cancer Res.
18:2220–2229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen P, Zhao D, Sun Y, Huang L, Zhang S
and Yuan Y: Protein inhibitor of activated STAT-1 is downregulated
in gastric cancer tissue and involved in cell metastasis. Oncol
Rep. 28:2149–2155. 2012.PubMed/NCBI
|
|
18
|
Jiang Z, Guo J, Xiao B, Miao Y, Huang R,
Li D and Zhang Y: Increased expression of miR-421 in human gastric
carcinoma and its clinical association. J Gastroenterol. 45:17–23.
2010. View Article : Google Scholar
|
|
19
|
Slot JW and Geuze HJ: A new method of
preparing gold probes for multiple-labeling cytochemistry. Eur J
Cell Biol. 38:87–93. 1985.PubMed/NCBI
|
|
20
|
Frens G: Controlled nucleation for the
regulation of the particle size in monodisperse gold suspensions.
Nature. 241:20–22. 1973.
|
|
21
|
Khlebtsov N and Dykman L: Biodistribution
and toxicity of engineered gold nanoparticles: A review of in vitro
and in vivo studies. Chem Soc Rev. 40:1647–1671. 2011. View Article : Google Scholar
|
|
22
|
Mesbahi A: A review on gold nanoparticles
radiosensitization effect in radiation therapy of cancer. Rep Pract
Oncol Radiother. 15:176–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lévy R, Shaheen U, Cesbron Y and Sée V:
Gold nanoparticles delivery in mammalian live cells: A critical
review. Nano Rev. 1:12010. View Article : Google Scholar
|
|
24
|
Coulter JA, Jain S, Butterworth KT,
Taggart LE, Dickson GR, McMahon SJ, Hyland WB, Muir MF, Trainor C,
Hounsell AR, et al: Cell type-dependent uptake, localization, and
cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomed.
7:2673–2685. 2012. View Article : Google Scholar
|
|
25
|
Tsai SW, Liaw JW, Kao YC, Huang MY, Lee
CY, Rau LR, Huang CY, Wei KC and Ye TC: Internalized gold
nanoparticles do not affect the osteogenesis and apoptosis of MG63
osteoblast-like cells: A quantitative, in vitro study. PLoS One.
8:e765452013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arvizo R, Bhattacharya R and Mukherjee P:
Gold nanoparticles: opportunities and challenges in nanomedicine.
Expert Opin Drug Deliv. 7:753–763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui W, Li J, Zhang Y, Rong H, Lu W and
Jiang L: Effects of aggregation and the surface properties of gold
nanoparticles on cytotoxicity and cell growth. Nanomedicine.
8:46–53. 2012. View Article : Google Scholar
|
|
28
|
Patra HK, Banerjee S, Chaudhuri U, Lahiri
P and Dasgupta AK: Cell selective response to gold nanoparticles.
Nanomedicine. 3:111–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thakor AS, Paulmurugan R, Kempen P,
Zavaleta C, Sinclair R, Massoud TF and Gambhir SS: oxidative stress
mediates the effects of Raman-active gold nanoparticles in human
cells. Small. 7:126–136. 2011. View Article : Google Scholar
|
|
30
|
Pan Y, Leifert A, Ruau D, Neuss S,
Bornemann J, Schmid G, Brandau W, Simon U and Jahnen-Dechent W:
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative
stress and mitochondrial damage. Small. 5:2067–2076. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Qu Y and Lü X: Global gene
expression analysis of the effects of gold nanoparticles on human
dermal fibroblasts. J Biomed Nanotechnol. 6:234–246. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hamano Y, Zeisberg M, Sugimoto H, Lively
JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A and Kalluri R:
Physiological levels of tumstatin, a fragment of collagen IV alpha3
chain, are generated by MMP-9 proteolysis and suppress angiogenesis
via alphaV beta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Egeblad M and Werb Z: New functions for
the matrix metal-loproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fanelli MF, Chinen LT, Begnami MD, Costa
WL Jr, Fregnami JH, Soares FA and Montagnini AL: The influence of
transforming growth factor-α, cyclooxygenase-2, matrix
metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in
epithelial-mesenchymal transition on overall survival of patients
with gastric cancer. Histopathology. 61:153–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mroczko B, Groblewska M, Łukaszewicz-Zajac
M, Bandurski R, Kedra B and Szmitkowski M: Pre-treatment serum and
plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue
inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer
patients. Clin Chem Lab Med. 47:1133–1139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sunami T, Yashiro M and Chung KH: ICAM-1
(intercellular adhesion molecule-1) gene transfection inhibits
lymph node metastasis by human gastric cancer cells. Jpn J Cancer
Res. 91:925–933. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rosette C, Roth RB, Oeth P, Braun A,
Kammerer S, Ekblom J and Denissenko MF: Role of ICAM1 in invasion
of human breast cancer cells. Carcinogenesis. 26:943–950. 2005.
View Article : Google Scholar : PubMed/NCBI
|
